Daihan Pharmaceutical Co.,Ltd. (KOSDAQ:023910)
South Korea · Delayed Price · Currency is KRW 26,650
-100 (-0.37%)
Sep 11, 2026, 3:30 PM KST
Daihan Pharmaceutical Market Cap
Daihan Pharmaceutical has a market cap or net worth of 156.7 billion as of September 11, 2026. Its market cap has decreased by -12.77% in one year.
Market Cap
156.70B
Enterprise Value
42.00B
Revenue
216.55B
Ranking
n/a
PE Ratio
5.69
Stock Price
26,650.00
ChartMarket Cap Chart
Since March 1, 2001, Daihan Pharmaceutical's market cap has increased from 22.26B to 156.70B, an increase of 603.96%. That is a compound annual growth rate of 7.94%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 156.70B | -8.89% |
| Dec 30, 2025 | 171.99B | 11.64% |
| Dec 30, 2024 | 154.06B | -5.59% |
| Dec 28, 2023 | 163.17B | -11.13% |
| Dec 29, 2022 | 183.60B | 6.62% |
| Dec 30, 2021 | 172.20B | -12.90% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Chong Kun Dang Holdings | 184.95B |
| FutureChem Co.,Ltd | 181.40B |
| BNC KOREA | 176.80B |
| Daewon Pharmaceutical | 170.82B |
| JW Lifescience | 170.33B |
| Samil Pharmaceutical Co.,Ltd | 153.87B |
| Ilsung Is | 153.32B |
| Hana Pharm | 149.47B |